Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01598389 · ClinicalTrials.gov registry record · NA

Eating Behaviors Among Weight-Discordant Siblings

A NA study of Obesity, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT01598389: Completed NA study of Obesity, sponsored by University of Pennsylvania.

NCT01598389 is a NA study of Obesity that has completed, run by University of Pennsylvania. The registered enrollment target is 94 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01598389, a NA study of Obesity, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare weight-discordant siblings in eating in the absence of hunger, caloric compensation, and the quality of their habitual diet. The investigator hypothesized that, within families and controlling for age differences, overweight and obese siblings would show greater eating in the absence of hunger, poorer caloric compensation, and poorer diet quality (e.g., increased percent of energy from fat and caloric beverages) compared to normal-weight siblings.

Primary Outcome

%COMPX, EAH, dietary intake variables

Conditions Studied

Interventions

  • OTHER Feeding study

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2008-10
Est. Completion 2011-05
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01598389 record still lists

NCT01598389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Feeding study is the first listed.

NCT01598389 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01598389 about?

NCT01598389 is a clinical study titled "Eating Behaviors Among Weight-Discordant Siblings". The purpose of this study was to compare weight-discordant siblings in eating in the absence of hunger, caloric compensation, and the quality of their habitual diet. The investigator hypothesized that, within families and controlling for age differences, overweight and obese siblings would show grea...

What is the current status of trial NCT01598389?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2008-10. Estimated completion is 2011-05.

What conditions does trial NCT01598389 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01598389?

The interventions under investigation include: Feeding study (OTHER).

Who is sponsoring clinical trial NCT01598389?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01598389 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01598389's enrollment target sits among peer trials

94 513th of 1053 higher than 541 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01598389, the US trial registry maintained by the National Library of Medicine. NCT01598389 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.